-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhongguancun announced that Beijing Huasu, a holding subsidiary of Sihuan Pharmaceutical, a wholly-owned subsidiary of the company's wholly-owned subsidiary, Shandong Huasu, and some drugs belonging to Duoduo Pharmaceutical were included in the “National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalogue”, and a total of 36 products produced by the company were included in the catalogue. Among them, products originally included in the 2025 catalogue, such as bisoprolol fumarate tablets and benidipine hydrochloride tablets, will continue to be included. The newly included products include Beijing Huasu's “Oxycodone Hydrochloride Sustained Release Tablets”, Shandong Huasu's “Bisoprolol Amlodipine Tablets”, Duoduo Pharmaceutical's “Bromhexine Hydrochloride Injection” and “Febustam Tablets”. The company suggests that future sales of products included in the catalogue may be affected by multiple factors such as changes in the market environment, and will not have a significant impact on current business performance. The catalogue will be officially implemented on January 1, 2027.

Zhitongcaijing·11/17/2026 08:17:06
Listen to the news
Zhongguancun announced that Beijing Huasu, a holding subsidiary of Sihuan Pharmaceutical, a wholly-owned subsidiary of the company's wholly-owned subsidiary, Shandong Huasu, and some drugs belonging to Duoduo Pharmaceutical were included in the “National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalogue”, and a total of 36 products produced by the company were included in the catalogue. Among them, products originally included in the 2025 catalogue, such as bisoprolol fumarate tablets and benidipine hydrochloride tablets, will continue to be included. The newly included products include Beijing Huasu's “Oxycodone Hydrochloride Sustained Release Tablets”, Shandong Huasu's “Bisoprolol Amlodipine Tablets”, Duoduo Pharmaceutical's “Bromhexine Hydrochloride Injection” and “Febustam Tablets”. The company suggests that future sales of products included in the catalogue may be affected by multiple factors such as changes in the market environment, and will not have a significant impact on current business performance. The catalogue will be officially implemented on January 1, 2027.